193 related articles for article (PubMed ID: 16169215)
1. Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives.
Fisher MJ; Backer RT; Collado I; de Frutos O; Husain S; Hsiung HM; Kuklish SL; Mateo AI; Mullaney JT; Ornstein PL; Paredes CG; O'Brian TP; Richardson TI; Shah J; Zgombick JM; Briner K
Bioorg Med Chem Lett; 2005 Nov; 15(22):4973-8. PubMed ID: 16169215
[TBL] [Abstract][Full Text] [Related]
2. Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivatives.
Briner K; Collado I; Fisher MJ; García-Paredes C; Husain S; Kuklish SL; Mateo AI; O'Brien TP; Ornstein PL; Zgombick J; de Frutos O
Bioorg Med Chem Lett; 2006 Jul; 16(13):3449-53. PubMed ID: 16650763
[TBL] [Abstract][Full Text] [Related]
3. Privileged structure-based ligands for melanocortin receptors-tetrahydroquinolines, indoles, and aminotetralines.
Fisher MJ; Backer RT; Husain S; Hsiung HM; Mullaney JT; O'Brian TP; Ornstein PL; Rothhaar RR; Zgombick JM; Briner K
Bioorg Med Chem Lett; 2005 Oct; 15(20):4459-62. PubMed ID: 16112861
[TBL] [Abstract][Full Text] [Related]
4. Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives.
Kuklish SL; Backer RT; Briner K; Doecke CW; Husain S; Mullaney JT; Ornstein PL; Zgombick JM; O'Brien TP; Fisher MJ
Bioorg Med Chem Lett; 2006 Jul; 16(14):3843-6. PubMed ID: 16697186
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and receptor binding studies of 3-substituted piperazine derivatives.
Bedürftig S; Wünsch B
Eur J Med Chem; 2006 Mar; 41(3):387-96. PubMed ID: 16446011
[TBL] [Abstract][Full Text] [Related]
7. New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of "THIQ".
Mutulis F; Yahorava S; Mutule I; Yahorau A; Liepinsh E; Kopantshuk S; Veiksina S; Tars K; Belyakov S; Mishnev A; Rinken A; Wikberg JE
J Med Chem; 2004 Aug; 47(18):4613-26. PubMed ID: 15317471
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
Herold F; Król M; Kleps J; Nowak G
Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
[TBL] [Abstract][Full Text] [Related]
9. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
[TBL] [Abstract][Full Text] [Related]
10. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.
Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA
Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.
Chen CW; Tran JA; Fleck BA; Tucci FC; Jiang W; Chen C
Bioorg Med Chem Lett; 2007 Dec; 17(24):6825-31. PubMed ID: 17964151
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.
Shi Q; Ornstein PL; Briner K; Richardson TI; Arnold MB; Backer RT; Buckmaster JL; Canada EJ; Doecke CW; Hertel LW; Honigschmidt N; Hsiung HM; Husain S; Kuklish SL; Martinelli MJ; Mullaney JT; O'Brien TP; Reinhard MR; Rothhaar R; Shah J; Wu Z; Xie C; Zgombick JM; Fisher MJ
Bioorg Med Chem Lett; 2006 May; 16(9):2341-6. PubMed ID: 16297618
[TBL] [Abstract][Full Text] [Related]
13. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of M(2)-selective muscarinic receptor ligands in the 1-[4-(4-arylsulfonyl)-phenylmethyl]-4-(4-piperidinyl)-piperazine family.
McCombie SW; Lin SI; Tagat JR; Nazareno D; Vice S; Ford J; Asberom T; Leone D; Kozlowski JA; Zhou G; Ruperto VB; Duffy RA; Lachowicz JE
Bioorg Med Chem Lett; 2002 Mar; 12(5):795-8. PubMed ID: 11859005
[TBL] [Abstract][Full Text] [Related]
15. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
Lee M; Rangisetty JB; Pullagurla MR; Dukat M; Setola V; Roth BL; Glennon RA
Bioorg Med Chem Lett; 2005 Mar; 15(6):1707-11. PubMed ID: 15745826
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.
Marinkovic D; Tucci FC; Tran JA; Fleck BA; Wen J; Chen C
Bioorg Med Chem Lett; 2008 Sep; 18(17):4817-22. PubMed ID: 18682322
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of proline based melanocortin receptor ligands.
Tian X; Field T; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Sheldon RJ
Bioorg Med Chem Lett; 2005 Jun; 15(11):2819-23. PubMed ID: 15911261
[TBL] [Abstract][Full Text] [Related]
18. Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands.
Tran JA; Chen CW; Tucci FC; Jiang W; Fleck BA; Chen C
Bioorg Med Chem Lett; 2008 Feb; 18(3):1124-30. PubMed ID: 18082401
[TBL] [Abstract][Full Text] [Related]
19. Enhanced FTase activity achieved via piperazine interaction with catalytic zinc.
Njoroge FG; Vibulbhan B; Pinto P; Strickland C; Bishop WR; Nomeir A; Girijavallabhan V
Bioorg Med Chem Lett; 2006 Feb; 16(4):984-8. PubMed ID: 16298128
[TBL] [Abstract][Full Text] [Related]
20. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
Takahashi T; Sakuraba A; Hirohashi T; Shibata T; Hirose M; Haga Y; Nonoshita K; Kanno T; Ito J; Iwaasa H; Kanatani A; Fukami T; Sato N
Bioorg Med Chem; 2006 Nov; 14(22):7501-11. PubMed ID: 16919461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
